Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 15

1.

Brief Report: Prolonged Viral Suppression Over a 12-Year Follow-up of HIV-Infected Patients: The Persistent Impact of Adherence at 4 Months After Initiation of Combined Antiretroviral Therapy in the ANRS CO8 APROCO-COPILOTE Cohort.

Protopopescu C, Carrieri MP, Raffi F, Picard O, Hardel L, Piroth L, Jadand C, Pierret J, Spire B, Leport C; ANRS CO8 APROCO-COPILOTE Study Group.

J Acquir Immune Defic Syndr. 2017 Mar 1;74(3):293-297. doi: 10.1097/QAI.0000000000001249.

PMID:
27861235
2.

Discussing HIV Status: Is It Easier After 10 Years of Antiretroviral Treatment? The ANRS CO8 APROCO-COPILOTE Cohort.

Préau M, Laguette V, March L, Rabaud C, Hardel L, Protopopescu C, Granier P, Pierret J, Leport C, Raffi F; ANRS CO8 APROCO-COPILOTE Study Group.

AIDS Behav. 2017 Jan;21(1):118-128. doi: 10.1007/s10461-016-1328-7.

PMID:
26910336
3.

Twelve-year mortality in HIV-infected patients receiving antiretroviral therapy: the role of social vulnerability. The ANRS CO8 APROCO-COPILOTE cohort.

Protopopescu C, Raffi F, Spire B, Hardel L, Michelet C, Cheneau C, Le Moing V, Leport C, Carrieri MP; ANRS CO8 APROCO-COPILOTE Study Group.

Antivir Ther. 2015;20(7):763-72. doi: 10.3851/IMP2960. Epub 2015 Apr 10.

4.

Low alcohol consumption as a predictor of higher CD4+ cell count in HIV-treated patients: a french paradox or a proxy of healthy behaviors? The ANRS APROCO-COPILOTE CO-08 cohort.

Carrieri MP, Protopopescu C, Raffi F, March L, Reboud P, Spire B, Leport C; ANRS CO8 APROCO-COPILOTE Study Group.

J Acquir Immune Defic Syndr. 2014 Apr 1;65(4):e148-50. doi: 10.1097/QAI.0000000000000087. No abstract available.

PMID:
24346641
5.

Satisfaction with care in HIV-infected patients treated with long-term follow-up antiretroviral therapy: the role of social vulnerability.

Préau M, Protopopescu C, Raffi F, Rey D, Chêne G, Marcellin F, Perronne C, Ragnaud JM, Leport C, Spire B; Anrs Co8 Aproco-Copilote Study Group.

AIDS Care. 2012;24(4):434-43. doi: 10.1080/09540121.2011.613909. Epub 2011 Oct 14.

PMID:
21999644
6.

Prolonged medically recorded treatment interruptions among HIV-infected patients on highly active antiretroviral therapy with controlled viremia: when physicians have to juggle patient negotiation and guidelines.

Protopopescu C, Roux P, Carrieri MP, Katlama C, Collin F, Besnier JM, Chêne G, Raffi F, Spire B, Leport C; ANRS CO8 APROCO-COPILOTE Study Group.

J Acquir Immune Defic Syndr. 2010 Apr 1;53(4):544-6. doi: 10.1097/QAI.0b013e3181ba1c48. No abstract available.

PMID:
20220376
7.

Factors associated with non-adherence to long-term highly active antiretroviral therapy: a 10 year follow-up analysis with correction for the bias induced by missing data.

Protopopescu C, Raffi F, Roux P, Reynes J, Dellamonica P, Spire B, Leport C, Carrieri MP; ANRS CO8 APROCO-COPILOTE Study Group.

J Antimicrob Chemother. 2009 Sep;64(3):599-606. doi: 10.1093/jac/dkp232. Epub 2009 Jul 14.

PMID:
19602563
8.

How do HIV-infected smokers react to cigarette price increases? Evidence from the APROCO-COPILOTE-ANRS CO8 Cohort.

Peretti-Watel P, Villes V, Duval X, Collin F, Reynes J, Sobel A, Protopopescu C, Chêne G, Spire B, Raffi F; ANRS CO8 APROCO-COPILOTE study group.

Curr HIV Res. 2009 Jul;7(4):462-7.

PMID:
19601784
9.

Uncontrolled viral replication as a risk factor for non-AIDS severe clinical events in HIV-infected patients on long-term antiretroviral therapy: APROCO/COPILOTE (ANRS CO8) cohort study.

Ferry T, Raffi F, Collin-Filleul F, Dupon M, Dellamonica P, Waldner A, Strady C, Chêne G, Leport C, Moing VL; ANRS CO8 (APROCO-COPILOTE) Study Group.

J Acquir Immune Defic Syndr. 2009 Aug 1;51(4):407-15. doi: 10.1097/QAI.0b013e3181acb65f.

PMID:
19474755
10.

Ten-year incidence and risk factors of bone fractures in a cohort of treated HIV1-infected adults.

Collin F, Duval X, Le Moing V, Piroth L, Al Kaied F, Massip P, Villes V, Chêne G, Raffi F; ANRS CO8 APROCO-COPILOTE study group.

AIDS. 2009 May 15;23(8):1021-4. doi: 10.1097/QAD.0b013e3283292195.

11.

Early evolution of plasma soluble TNF-alpha p75 receptor as a marker of progression in treated HIV-infected patients.

Morlat P, Pereira E, Clayette P, Derreudre-Bosquet N, Ecobichon JL, Benveniste O, Saves M, Leport C; ANRS CO8 Aproco-Copilote Study Group.

AIDS Res Hum Retroviruses. 2008 Nov;24(11):1383-9. doi: 10.1089/aid.2007.0293.

PMID:
18928394
12.

Pregnancy may be followed by an inflexion of the immune reconstitution in HIV-infected women who receive antiretroviral drugs before conception.

Le Moing V, Taïeb A, Longuet P, Lewden C, Delcey V, Drobacheff MC, Chêne G, Leport C; ANRS CO8 (APROCO-COPILOTE) study group.

HIV Med. 2008 Nov;9(10):897-900. doi: 10.1111/j.1468-1293.2008.00641.x. Epub 2008 Sep 14.

13.

Occult hepatitis B in HIV-HCV coinfected patients.

Piroth L, Lafon ME, Binquet C, Bertillon P, Gervais A, Lootvoet E, Lang JM, De Jaureguiberry JP, Chene G, Leport C; ANRS CO8 APROCO-COPILOTE Study Group.

Scand J Infect Dis. 2008;40(10):835-9. doi: 10.1080/00365540801918511.

PMID:
18609222
14.

Evolution of plasma hepatitis C virus load in patients coinfected by HIV and hepatitis C Virus started on a protease inhibitor-containing antiretroviral regimen, Agence Nationale de Recherches sur le SIDA CO8 APROCO-COPILOTE cohort.

Neau D, Trimoulet P, Pereira E, Lafon ME, Gervais A, Ragnaud JM, Dupon M, Ecobichon JL, Chêne G, Raffi F; ANRS CO8 APROCO-COPILOTE Study Group.

J Acquir Immune Defic Syndr. 2008 Jun 1;48(2):227-9. doi: 10.1097/QAI.0b013e31816d9cc3. No abstract available.

PMID:
18520685
15.

Indinavir trough concentration as a determinant of early nephrolithiasis in HIV-1-infected adults.

Collin F, Chêne G, Retout S, Peytavin G, Salmon D, Bouvet E, Raffi F, Garraffo R, Mentré F, Duval X; ANRS CO8 Aproco-Copilote Study Group.

Ther Drug Monit. 2007 Apr;29(2):164-70.

Supplemental Content

Loading ...
Support Center